Back to results
US 10,039,812 B2Granted
Therapeutic for treating clostridium difficile infection
AssigneeLondon School of Hygiene and Tropical Medicine
InventorsLisa Dawson, Brendan Wren
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeLondon School of Hygiene and Tropical Medicine
InventorsLisa Dawson, Brendan Wren
Estimating the term…
The invention relates to deoxyribonuclease for use in the treatment of a suspected or existing C. difficile infection; a pharmaceutical or veterinary composition or formulation comprising at least deoxyribonuclease for use in the treatment of a suspected or existing C. difficile infection; a combination therapeutic comprising at least deoxyribonuclease for use in the treatment of a suspected or existing C. difficile infection; a method of treating a mammal suspected of being infected with, or infected with, C. difficile comprising the use of at least deoxyribonuclease; a method of cleaning or sterilizing a material or product comprising the use of at least deoxyribonuclease; and a cleaning or sterilizing product impregnated with or containing at least deoxyribonuclease.
A therapeutic composition for degrading Clostridium difficile biofilm, comprising a mammalian deoxyribonuclease or functional fragment thereof, and vancomycin, wherein the composition exhibits antibiotic activity against Clostridium difficile biofilm.
Dependencies are inferred from the claim text.